Doctrine — Overwatch 2's Vampiric Support and the Two-Charge Infuse Gamble

At BlizzCon 2026, Blizzard didn't drop a three-minute action trailer for Doctrine. They dropped a toolkit. And inside that toolkit was a single number that made me stop mid-livestream: two. Exactly two Infuse charges. Not one, not three, not an energy bar that fills over time. Two — the number of someone who has to know what they are giving up. Two Infuse charges is not a minor detail. It is the entire design philosophy of this new support hero. With one charge, the ability is almost automatic — you press it when needed, without thinking. With three or more, you have room to err and correct. But with exactly two, every Infuse press is a commitment. And in a game where a team fight lasts 15 to 20 seconds, a wrong commitment means the whole team goes down. I have watched Overwatch matches in Seoul long enough to know one thing: support metas are not written by inspiration. They are written by numbers. Doctrine has just thrown down a problem that both tier-1 and tier-2 Korea will have to solve within weeks. Overwatch 2 runs on a rhythm any analyst can measure: each season, one or two new heroes join, and each new hero leaves a cut in the meta before being rebalanced. People call it a hype cycle. I call it by a more precise name: a balance oscillation cycle. When a new support arrives, there are three phases. The discovery phase — roughly the first 7 to 14 days, when players are still learning the kit and win rates are noisy. The shaping phase — when teams find the optimal combo and win rates stabilise. And the balancing phase — when Blizzard ships the first patch, usually 4 to 6 weeks later. With Doctrine, the discovery phase will matter more than usual, because this is not a support built on damage or on mobility. This is a support built on endurance. And in Overwatch 2, endurance supports share a trait analysts tend to overlook: they are not measured by healing output, but by their ability to keep the backline alive. The history of Overwatch supports is a chain of evidence for that claim. Ana dominated not because she healed the most, but because Sleep Dart and Nano Boost opened team-fight windows that opponents could not break. Brigitte was nerfed repeatedly not because she healed wrong, but because she stretched the backline survival window beyond design tolerance. Baptiste became a default pick at many ranks not because he healed fast, but because Immortality Field created a programmable interval of invulnerability. And Kiriko, after three underrated weeks, climbed to irreplaceability not because her kunai dealt damage, but because her Suzu erased every burst plan an opponent could draw up. What is the common thread among every support that has ever dominated a meta? It is the ability to create an interval in which the backline can survive a burst of damage. In the internal analysis documents Korean teams commonly use, this concept has its own name: the survival window. And Doctrine, with a vampiric mechanic and two Infuse charges, aims directly at widening that window. Doctrine's kit revolves around a single axis: Infuse — a two-charge ability that amplifies other abilities. Specifically, Infuse can be used to increase mobility or increase healing output, depending on which ability the player chooses to amplify. This is a costed-choice mechanic — each charge is a scarce resource, and scarce resources always produce decision pressure. Why does exactly two matter so much? Picture a typical team fight at high rank. For the first 15 seconds, your team must absorb the opening burst. Over the next 10 seconds, your team must counter-attack. If Doctrine had three Infuse charges, she could amplify healing for the first exchange, amplify mobility to dodge the second, and still hold one charge for a surprise. With two, she must choose: survive, move, or strike. She cannot have all three. The number two turns Doctrine from a support who can do many things into a support who must choose the right thing. That is a design aimed at players with high game sense, not players with fast hands. And in Korea's professional environment — where teams rehearse probabilistic scenarios — this is the kind of hero that can be mined to its very bottom. The second notable feature is the vampiric mechanic. Blizzard has not published a specific lifesteal rate, but the naming and kit description point to an active lifesteal. This means Doctrine does not only heal allies; she sustains herself. In Overwatch 2 history, self-sustaining supports tend to produce two effects: they reduce the burden on the backline, and they increase the ability to hold front positions. If Doctrine can stand where other supports cannot, she will change the geometry of a fight — not merely the healing output. The third feature is the Perk system. Two Perks revealed — Cost of Life and Transfusion — suggest Blizzard is designing Doctrine to let players customise their role situationally. Cost of Life hints at an exchange mechanic: perhaps trading health for effect, or time for power. Transfusion hints at a blood-transfer mechanic: perhaps moving health from herself to an ally, or transferring the lifesteal effect to an ally. If Transfusion genuinely transfers lifesteal to a DPS, then Doctrine is not merely a support — she is an amplifier. Notably, Perks cannot be Infused. In other words, the Infuse mechanic applies only to base abilities, not to Perks. That creates a second layer of decision-making: players choose not only which ability to amplify, but which Perk to pair with that amplification strategy. Two decision layers on one support is a level of complexity Overwatch 2 has never pushed this far in the role. There is a historical parallel worth pondering. When Kiriko launched, her kit revolved around two axes: protecting allies with Suzu, and applying damage pressure with the kunai. The community took about three weeks to realise her real value lay in Suzu, not the kunai. With Doctrine, I expect the recognition process to take longer, because her value lies in something harder to measure: timing. This is where data will have to speak. In week one, Doctrine's win rate will be noisy with the novelty factor — players unfamiliar with the kit, opponents unsure how to counter it. But there is one metric I will track more closely than win rate: Infuse usage per life. If that number is low, Doctrine is being played below her potential. If it spikes high, she is being overplayed — Infuse pressed as reflex rather than decision. The optimal zone lies in the middle, and that middle zone is what separates good players from great ones. Based on my experience watching matches in Seoul, tier-1 Korean teams share one admirable habit: they do not play new heroes on instinct. They play them on models. They will split Doctrine into situational segments — open fight, indoor fight, objective contest, retreat — and assign each segment an optimal Infuse pattern. That is why I believe Doctrine will not mature in tier-2, but in tier-1, and faster than expected. Her value depends on decision quality, and decision quality is exactly what Korean tier-1 teams invest in most. However, this is the point where I must state plainly something few analyses are willing to say. Everything above is built on a data foundation that is not yet solid. Blizzard has not published a specific lifesteal rate. Has not published the Infuse recharge time. Has not published the exact effects of the two Perks. Has not published the base healing figure. And above all, all current information about Doctrine comes from a single event — BlizzCon 2026 — with very few independent sources to verify it. This is a position any serious analyst must acknowledge: we are analysing a kit whose key variables remain unpublished. Score is a liar; data is the only witness I trust. But at this moment, the witness has not been summoned. And an honest analyst must say so, rather than assign Doctrine numbers for which no evidence exists. There are three scenarios I consider plausible for Doctrine, and I am staking public bets on them. Scenario one: Doctrine launches balanced, becoming a tier-1 support in roughly 60 to 70 percent of professional matches. Her win rate hovers around 50 to 52 percent, and teams use her as a tactical pick for endurance compositions. I assign this scenario a 45 percent probability. Scenario two: Doctrine launches too strong. A high lifesteal rate plus two Infuse charges makes her a support who almost cannot die. Her win rate exceeds 55 percent, Blizzard ships an emergency patch within two weeks, and Doctrine goes through a nerf cycle the community usually calls the afterbirth pain. I assign this 30 percent. Scenario three: Doctrine launches too weak. The two-charge Infuse mechanic proves too demanding in a fast-paced fight environment. Players return to familiar supports, and Blizzard has to buff Doctrine in a mid-season patch — which often produces a sleeping support that erupts late. I assign this 25 percent. I will be the first to update these numbers if real data drifts away from the model. That is not weakness in reasoning. That is the discipline of someone who works with data. There is another blind spot I want to raise. It is the difference between healing a lot and saving allies. In Overwatch 2 these two concepts are often conflated, but they differ in nature. A support can heal enormously and still let allies die, if the healing arrives at the wrong moment. Conversely, a support with lower healing that arrives at the right moment can save more lives. Doctrine, with her two-charge Infuse, is clearly designed toward the second. Her value lies not in the healing figure, but in the timing of healing. And timing is something data can only measure once enough match samples exist — not after one BlizzCon showcase. This is why I am in no hurry to predict Doctrine's win rate. I only predict the design shape. And that shape — a support demanding costed choices — is a direction I rate highly, because it pushes the support role out of the safe zone of reflex and into the zone of thought. There is one more thing few people notice when discussing a new support. It is Doctrine's effect on the transfer market for Overwatch teams. Historically, whenever a new support becomes a meta default, the value of specialists on that hero spikes within one to two transfer windows. Kiriko is the clearest example: once she became default, teams were willing to pay more for players with a strong Kiriko pool. With Doctrine, I expect a similar but slower effect — because the skill required to play her well is decision-making, not mechanics. And decision-making is harder to measure in tryouts. If my prediction holds, we will see an interesting trend in the next transfer window: teams will prioritise support players with a history of playing resource-management heroes — such as Ana or Baptiste — over players who are only strong in reflex. Doctrine will not only change the meta. She will change the valuation criteria for support players. I follow the transfer market not to catch news, but to catch patterns. And the first rule of any new Overwatch hero is: their true value is not decided on launch day, but in week three, when both players and opponents understand the kit. Doctrine will not escape that rule. What I will do over the next three weeks is simple. I will track Infuse usage per life, win rate by composition, and the average interval between two Infuse casts during team fights. If the data shows Doctrine is being played correctly — meaning Infuse is being used deliberately, not reflexively — she will become part of Korea's professional meta before the season closes. And if the data says otherwise, I will be the first to publish a correction. A crisis is just a dataset that has not been cleaned. And a new support hero, in the end, is just such a dataset — waiting to be read correctly, read honestly, and corrected when necessary. Before the ball rolls, the number has already whispered the result. With Doctrine, the number is whispering two things: two charges, and patience. Whoever reads both correctly will win.